Edition:
India

Valneva SE (VLS.PA)

VLS.PA on Paris Stock Exchange

3.50EUR
18 Apr 2019
Change (% chg)

€0.00 (+0.00%)
Prev Close
€3.50
Open
€3.51
Day's High
€3.51
Day's Low
€3.48
Volume
32,233
Avg. Vol
73,348
52-wk High
€4.19
52-wk Low
€3.01

About

Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and... (more)

Overall

Beta: 1.88
Market Cap(Mil.): €226.54
Shares Outstanding(Mil.): 77.58
Dividend: --
Yield (%): --

Financials

Emergent-Valneva Zika vaccine clears early trial

A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

20 Nov 2018

Emergent-Valneva Zika vaccine clears early trial

Nov 19 A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

20 Nov 2018

Earnings vs. Estimates